Guidance

Guidance: NHS (Pharmaceutical Services) Regulations 2012

Guidance to help primary care trusts in the assessment and determination of applications to provide NHS pharmaceutical services

Documents

Regulations under the Health Act 2009: Market entry by means of Pharmaceutical Needs Assessments Information for Primary Care Trusts Executive Summary and Chapters 1-4

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 5: Current needs

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 6: Future needs

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 7: Improvements or better access to services

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 8: Unforeseen benefits

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 9: Future improvements or better access to services

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 10: Relocations that do not result in significant change to pharmaceutical services provision

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 11: Distance-selling premises

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 12: Changes of ownership

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 13: Changes of ownership and relocations

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 14: Provision of pharmaceutical services in controlled localities

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 15: Dispensing doctors service provision

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Annexes

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Performance sanctions including market exit for contractors providing pharmaceutical services: Information for Primary Care Trusts

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Schedule 7 to the NHS (Pharmaceutical Services) Regulations 2012 containing transitional provisions

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

Guidance is published alongside the NHS (Pharmaceutical Services) Regulations 2012 to help primary care trusts in the assessment and determination of applications to provide NHS pharmaceutical services under the new market entry test and the new performance sanctions regime.

An addendum has also been produced to the transitional provisions guidance published on 23 July 2012 with regard to applications which do not have an equivalent provision in the 2012 Regulations but have been notified.